Significant Ownership of Sofinnova Venture Partners X, L.P.
- Signature - Title
- /s/ Nathalie Auber - Nathalie Auber / Attorney-in-Fact
- Location
- Menlo Park, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Venture Partners X, L.P..
Follow Filing Activity
Follow Sofinnova Venture Partners X, L.P. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Sofinnova Venture Partners X, L.P.
Significant Ownership of Sofinnova Venture Partners X, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Class A Common Stock, $0.001 par value | 4% | $128,465,927 | 2,847,837 | Dr. Maha Katabi ("Katabi") | 10 Dec 2025 | ||
| JBIO | Jade Biosciences, Inc. | Common Stock, par value $0.0001 per share | 0.3% | $1,617,308 | 107,391 | Sofinnova Venture Partners X, L.P. ("SVP X") | 28 Apr 2025 |
Schedules 13D/G Reported by Sofinnova Venture Partners X, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.